Learn about the latest developments surrounding genetics, Mendelian randomisation studies and animal and human biology in lipid, lipoprotein and apolipoprotein research. Results from recently completed intervention trials will also be presented.
We have created three sub-tracks in the dyslipidaemia track: Basic Science, Translational Research and Clinical studies. Create your own ‘tailor made’ programme throughout our entire event in Amsterdam.
Highlights of the dyslipidaemia track:
Enrich your knowledge with the most recent findings on the importance of innate and acquired immunity, low grade inflammation. Learn about their interactions with both monocytic and endothelial cells for the development of atherosclerotic vascular disease.
The Basic Science, Translational Research and Clinical studies sub-track allow you to compile a personal tailor-made programme of the pathogenesis of atherosclerosis track.
Highlights of the pathogenesis of atherosclerosis track include:
This track revisits and integrates epidemiologic data from the previous as well as the current century. It addresses association versus causality of the risk factor concept. You will explore the reconciliation of the most recent results of Mendelian randomisation studies with the outcomes of the Emerging Risk Factor Collaboration.
Highlights of the epidemiology of CVD track include:
Bring your knowledge up to speed by learning about the latest findings in both effective primary and secondary prevention.
Lifestyle measures include cessation of smoking, dietary measures, weight reduction and exercise. Pharmacological interventions cover coagulation, platelet inhibition, diabetes mellitus, hypertension, weight reduction as well as dyslipidaemia. Recent insights from randomised interventional trials in the secondary prevention arena will also be covered.
A thorough discussion of the European, US and UK guideline updates as published late 2014, will help you put these intervention outcomes into perspective.
Progression and prevention of atherosclerosis and a translation to relevance.